FAQ
Log In
Friday 20th October 2017
News
 › 
 › 

Draft NICE guidance welcomed by BHF

1st April 2010

The British Heart Foundation has welcomed new draft guidance from the National Institute for Health and Clinical Excellence on Dronedarone.

NICE recommends limited use of dronedarone for atrial fibrillation (AF). June Davison, Senior Cardiac Nurse at the BHF, said the organisations supported the committee's conclusion that dronedarone should not be recommended as a first-line anti-arrhythmic drug on the basis of current evidence, but that dronedarone should be available for people who find their existing drug ineffective or cannot tolerate the drug they are prescribed.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2017